AZASITE Phase II trial results for blepharitis - Ophthalmology Times Europe
Links shared publicly online about this topic.
- 1,275total visits
AZASITE Phase II trial results for blepharitis - Ophthalmology Times Europe
Used for the treatment of blepharitis, AZASITE (azitthromycin ophthalmic solution) from Inspire Pharmaceuticals Inc., was used in two clinical trials in patients with anterior blepharitis. One trial had a two-week treatment period, the other trial a four-week treatment period.
View full resource at oteurope.com
Tags: Eyelid Disorder, Pharma, Clinical Trial, Ophthalmology
Most Recently Shared on March 31, 2010 at 11:00 am By:
AZASITE Phase II trial results for blepharitis http://ow.ly/1r9gq
Advertisement
